Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Role of Brain Dopamine in Chronic Pain
Sponsor: University of Rochester
Summary
Chronic pain is associated with plasticity in the brain limbic system composed mainly of the amygdala, hippocampus, ventral striatum, and cingulate cortex (ACC) /medial prefrontal cortex (mPFC). These brain areas, especially the ventral striatum, receive dopaminergic input from the ventral-tegmental area (VTA). Although there is a significant literature now showing that limbic brain tracks chronic pain intensity and predicts the risk of transition from sub-acute to chronic pain, the role of dopaminergic input to the limbic brain and the change thereof which occurs in chronic pain, is still not clear. Given the role of dopamine in motivational control and the loss of motivation associated with chronic pain understanding how dopaminergic transmission is altered in the limbic brain of chronic pain patients is critical to the understanding of the pathophysiology of chronic pain. Therefore, the overall aim of this project is to use brain imaging to study how dopaminergic transmission through the oral administration of pro-dopaminergic medications carbidopa/levodopa (CD/LD) and methylphenidate will modulate the brain signature of chronic pain. Chronic pain subjects will be scanned at baseline (no drug administration) and three times after treatment with the two drugs or placebo. The protocol will follow a randomized double-blind approach.
Official title: The Role of Dopamine in the Central Neural Signature of Chronic Pain
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2024-01-31
Completion Date
2026-01-22
Last Updated
2025-01-15
Healthy Volunteers
No
Conditions
Interventions
Methylphenidate
0.5 mg/kg
carbidopa-levodopa
25 mg/100 mg
Placebo
oral pill
Locations (1)
University of Rochester Medical Center
Rochester, New York, United States